ALEXION PHARMACEUTICALS, INC.

(ALXN)
SummaryQuotesChartsNewsRatingsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about ALEXION PHARMACEUTICALS, INC.
05/05Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial in adults with neuromy..
AQ
04/28Ultomiris approved in the US for adults with generalised myasthenia gravis
AQ
04/26BREAKING PMPRB NEWS : Another Win For Patients And The Innovative Pharmaceutical Industry
AQ
04/11PMPRB UPDATE : PMPRB Is Accepting Intervener Leave Applications For SOLIRIS Re-hearing
AQ
03/31SCC Leave Denied In Alexion Pharmaceuticals Inc v Canada (Attorney General)
AQ
03/29PMPRB UPDATE : Supreme Court Refuses To Hear Appeal From Decision Restricting Canada's Pat..
AQ
03/18Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litig..
AQ
03/17AstraZeneca reaches settlement agreement resolving patent litigation related to Ultomir..
AQ
03/01AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement t..
AQ
03/01Alexion, Astrazeneca's Rare Disease Group and Neurimmune Closes Deal for Commercializin..
CI
02/10AstraZeneca sees $4B in COVID vaccine sales as revenue soars
AQ
02/07PRIORITY NEWS : Referral To EBA Gives PCT Joint Applicants Reasons To Rejoice In 2022
AQ
01/25The 2022 PMPRB Outlook For Pharmaceutical Patentees In Canada
AQ
01/10AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to..
AQ
01/07AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to..
AQ
01/07Alexion Enters into an Exclusive Global Collaboration and Licence Agreement with Neurim..
CI
2021M&A market remains strong despite decline in activity
AQ
2021LIFE SCIENCES : Vavilov And The New Regulatory Environment
AQ
2021ALEXION PHARMACEUTICALS : Canada Seeks Leave To Appeal To The Supreme Court In PMPRB Exces..
AQ
2021Alexion Pharmaceuticals, Inc. completed the acquisition of remaining majority stake in ..
CI
2021OCULAR THERAPEUTIX : Announces appointment of karen-leigh edwards as senior vice president..
AQ
2021AstraZeneca's Alexion to Advance and Accelerate Ongoing Phase III Clinical Development ..
CI
2021Alexion Pharmaceuticals, Inc. agreed to acquire remaining majority stake in Caelum Bios..
CI
2021ASTRAZENECA : to Mandate COVID-19 Shots for US Staff
MT
2021ALEXION PHARMACEUTICALS : FCA Remits Pricing Decision On ALEXION'S SOLIRIS To PMPRB
AQ
2021ASTRAZENECA : Rare Disease Drug Improves Copper Mobilization in Late-Stage Study
MT
2021ALEXION PHARMACEUTICALS : Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotroph..
AQ
2021FTSE : Consumer staples, financials lift FTSE 100 after worst week since February
RE
2021ASTRAZENECA : Unit Alexion Discontinues Late-Stage Trial of ALS Drug Candidate Due to Lack..
MT
2021FTSE 100 Falls as Growth Fears Persist; More Volatility Possible
DJ
2021AstraZeneca's antibody therapy prevents COVID-19, study shows
RE
2021Alexion Discontinues CHAMPION-ALS
CI
2021ASTRAZENECA : Alexion to Discontinue Ultomiris Phase 3 ALS Trial
DJ
2021ALEXION PHARMACEUTICALS : Canadian Drug Price Review Board Reined In
AQ
2021"THIS COURT DOES NOT SIGN BLANK CHEQ : Federal Court Of Appeal Reverses Canada's Patented ..
AQ
2021Exclusive - AstraZeneca exploring options for COVID-19 vaccine business - executive
RE
2021London Indexes Boosted by Positive Welcome to Most Earnings
DJ
2021ASTRAZENECA : First-Half Revenue Soars on New Medicines, COVID-19 Vaccine Boost
MT
2021BEN VAN BEURDEN : London Shares Rise as Miners, Oil Stocks Gain; S&N, BT Fall
DJ
2021FTSE Edges Higher, Speculators Could Rebuild Bets on Stronger Pound
DJ
2021AstraZeneca Lifts 2021 Guidance After Alexion Acquisition; Posts Lower 2Q Profit -- Upd..
DJ
2021AstraZeneca 2Q Net Profit Dropped Despite Higher Revenue; Raises Guidance
DJ
2021ASTRAZENECA : H1 Profit Rises 42% Amid Growth In Oncology, Respiratory
MT
2021ASTRAZENECA : EU regulator backs AstraZeneca drug for rare blood disorder in children
RE
2021ASTRAZENECA : EU regulator endorses AstraZeneca drug for rare blood disorder in children
RE
2021ALEXION PHARMACEUTICALS : Termination of Material Definitive Agreements (Form 8-K)
PU
2021Alexion Pharmaceuticals, Inc. Announces Board Cessations
CI
2021ASTRAZENECA : Closes on Acquisition of Alexion
MT
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 Health Care
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Composite 1500
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from INDUSTRIALS
CI
2021Alexion Pharmaceuticals, Inc.'s Equity Buyback announced on October 23, 2019, has expir..
CI
2021AstraZeneca PLC completed the acquisition of Alexion Pharmaceuticals, Inc..
CI
2021Alexion Pharmaceuticals, Inc.'s Equity Buyback announced on July 21, 2021, has expired.
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 Value
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Global 1200
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 Growth
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from FTSE All-World Index
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from NASDAQ Composite Index
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P TMI Index
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 EQUAL WEIGHTED
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Global BMI Index
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Biotechnology Select Industr..
CI
2021FTSE Bounces Back Closing Higher Despite Delta-Variant Concerns
DJ
2021FTSE Rises, Risk Aversion Likely to Keep Pound Under Pressure
DJ
2021Alexion Pharmaceuticals, Inc. Announces Revenue Results for the Three Months and Six Mo..
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from NASDAQ Biotechnology Index
CI
2021ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from NASDAQ-100 Index
CI
2021Wall Street drops as Delta variant drives fears
RE
2021CLOSE UPDATE : US Stocks Drop Friday as COVID Cases Rise, Consumer Sentiment Fades Amid St..
MT
2021Wall Street ends down as Delta variant drives fears
RE
2021SECTOR UPDATE : Health Care Stocks Manage to Largely Sidestep Friday Selldown as Biotech S..
MT
2021Wall Street drops as Delta variant raises fears
RE
2021Equities Slip Midday After Strong Retail Sales, Surprise Drop in Consumer Sentiment
MT
1  2  3  4  5  6  7  8  9  10Next